Effects of Tight Blood Pressure Control on Glomerular Hypertrophy in a Model of Genetic Hypertension and Experimental Diabetes Mellitus.
From: Laboratory of Renal Pathophysiology, Nephrology Unit, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Life sciences
- Publish Date: Oct 2006
- ISSN: 0024-3205
- Volume: 79
- Issue: 22
- Pages: 2135-43
- Medium: Print
- Language: English
- Citation (JAMA): Amazonas Roberto Bleuel, Lopes de Faria José B, et al. Effects of Tight Blood Pressure Control on Glomerular Hypertrophy in a Model of Genetic Hypertension and Experimental Diabetes Mellitus.. Life Sci. Oct 2006;79:2135-43
Abstract
The aim of this study was to evaluate the effect of prevention of hypertension on glomerular hypertrophy, renal cell replication and accumulation of glomerular fibronectin in a model of genetic hypertension and experimental diabetes. Four-week-old streptozotocin induced spontaneously hypertensive rats (SHR) were randomized for no treatment, or for treatment with captopril, losartan or triple therapy (hydrochlorothiazide, reserpine and hydralazine) for 20 days. Increase in systolic blood pressure was equally prevented by captopril (118+/-15 mmHg), losartan (111+/-9) and triple therapy (112+/-14, p<0.0001). Glomerular size was higher (p<0.005) in diabetic SHR (27,300+/-2130 microm(2)) compared with non-diabetic SHR (23,800+/-307). The antihypertensive therapy with captopril (23,900+/-175), losartan (23,800+/-120), and triple therapy (23,400+/-210) prevented the glomerular enlargement in diabetic SHR. Glomerular expression of fibronectin was increased in diabetic SHR (7.61+/-1.22 densitometric unit) as compared to the controls (2.27+/-2.15, p<0.0001), and was decreased (p<0.0001 vs diabetic SHR) with captopril (2.49+/-1.42), losartan (1.57+/-1.1) and triple therapy (2.04+/-1.42). The number of replicating glomerular cell significantly decreased in diabetic SHR and it was restored by all three antihypertensive regimes. The glomerular expression of p27(Kip1) was increased in diabetic SHR but it was not modified by antihypertensive treatment. Strict blood pressure control, in diabetic SHR independently of the class of antihypertensive agent, restores glomerular hypertrophy and renal cellular replication, and prevents the increment in glomerular fibronectin.
Mesh Headings (Keywords): Animals, Antihypertensive Agents, Blood Pressure, Captopril, Diabetes Mellitus, Experimental, Hypertension, Immunohistochemistry, Kidney Glomerulus, Rats, Rats, Inbred SHR
Check for Full Text / PubMed Unique Identifier (PMID): 16890245
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.